ENTITY

RUA Life Sciences (RUA LN)

6
Analysis
Health Care • United Kingdom
RUA Life Sciences is a medical device company that provides next-generation polymers, services, and products to the medical device industry. The company operates through four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular, and RUA Structural Heart, focusing on licensing Elast-Eon polymers, contract manufacturing, developing vascular grafts and soft tissue patches, and creating polymeric heart valves. Headquartered in Ayrshire, United Kingdom, the company was incorporated in 1996 and formed the RUA Life Sciences group in April 2020 through the acquisition of RUA Medical Devices Ltd by AorTech International plc.
more
•21 Apr 2026 00:02•Issuer-paid

Hybridan Research: RUA Life Sciences plc

Progress was reported at the AGM Trading update given on 17 March 2026 for the 18 months to the new year-end September 2025).

Logo
Hybridan
115 Views
Share
•09 Feb 2026 18:02•Issuer-paid

Hybridan Small Cap Feast: 2 February 2026

As a result, the Customer renewed for a further three-years with a total contract value in excess of £160,000 - this takes Acuity's contracted...

Logo
Hybridan
127 Views
Share
•20 Nov 2025 09:47•Issuer-paid

Hybridan Research: RUA Life Sciences: Journey to a Higher Value

The new accounting date is to September 2025, changed from March, so the next full audited report is for 18 months to be announced in January 2026.

Logo
Hybridan
170 Views
Share
•07 Jul 2026 19:03•Issuer-paid

Cake Box Holdings PLC - Hybridan Small Cap Feast: 30 June 2026

The retailer of fresh cream celebration cakes reports full year results to 31 March 2026. Revenue increased 39.5% to £59.69m, EBITDA was up 39.9%...

Logo
Hybridan
111 Views
Share
bullish•Macfarlane
•20 May 2026 07:51•Issuer-paid

Hybridan Small Cap Feast: 12 May 2026

he UK and European-based manufacturer of its proprietary Neptune melt-blown material and specialist in acoustic and thermal insulation solutions...

Logo
Hybridan
95 Views
Share
x